Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Friday 20 October, 2017

GlaxoSmithKline PLC

Director/PDMR Shareholding

RNS Number : 2490U
GlaxoSmithKline PLC
20 October 2017
 

GlaxoSmithKline plc (the 'Company')

 

Transaction notification

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Mr B McNamara

b)

Position/status

CEO, Consumer Healthcare

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

American Depositary Shares ('ADSs')

ISIN: US37733W1053

 

b)

Nature of the transaction

Acquisition of ADSs following the re-investment of dividends paid to shareholders on 12 October 2017 on shares held in the Deferred Annual Bonus Plan Post-Tax.

c)

Price(s) and

volume(s)

Price(s)

Volume(s)

$41.1310

25.454

 

d)

Aggregated information

 

Aggregated volume Price

n/a (single transaction)

e)

Date of the transaction

2017-10-19

f)

Place of the transaction

 

New York Stock Exchange (XNYS)

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHEBLFLDBFFFBF

a d v e r t i s e m e n t